ArticleJournal of food science2026
Brazilian Green Propolis and Essential Oil Residues Improve Metabolic Dysfunction by Modulating Key Hepatic Lipogenic Genes in High-Fat Diet-Fed Mice.
Article in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Obesity is closely associated with metabolic dysfunction, leading to impaired glucose and lipid homeostasis and contributing to the development of metabolic dysfunction-associated liver disease (MASLD). Propolis is a bee-derived natural product rich in bioactive compounds and widely recognized for its antioxidant, anti-inflammatory, and immunomodulatory properties. This study evaluated the effects of Brazilian green propolis, a hydroalcoholic green propolis extract, and a residue-derived extract obtained from the essential oil extraction process on high-fat diet-induced MASLD in male C57BL/6 mice. Animals were allocated into five groups: control diet (10% fat), high-fat (HF) diet (50% fat), HF supplemented with green propolis (HFGP, 2%), HF supplemented with green propolis extract (HFGPE, 2%), and HF supplemented with green propolis residue (HFGPR, 2%) for 12 weeks. Chemical analysis identified artepillin C as a major constituent in both extracts. Supplementation with Brazilian green propolis and its derivatives significantly reduced body weight gain, improved lipid profile and glycemic control, and exerted marked antioxidant effects. In addition, propolis supplementation downregulated the expression of key lipogenic genes and promoted a pronounced anti-inflammatory response, resulting in a significant attenuation of hepatic steatosis. Collectively, these findings indicate that Brazilian green propolis effectively mitigates obesity-induced metabolic disturbances and tissue damage. Notably, residue-derived extracts from the essential oil extraction process represent a sustainable, cost-effective, and promising therapeutic strategy for obesity and its associated metabolic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.